PMID: 8964200Feb 1, 1996Paper

Insulin and insulin-like growth factor-I: their role as risk factors in the development of diabetic cardiovascular disease

Diabetes Research and Clinical Practice
B Göke, H C Fehmann

Abstract

Experimental data support a role for insulin and insulin-like growth factor-I (IGF-I) in the pathophysiology of vascular complications in diabetes. Clinical data for both hormones are less convincing, mainly because the various studies vary in methodologies, sample sizes, and populations. So far, by epidemiological means, insulin's vascular toxicity has been shown only in middle-aged non-diabetic men. Furthermore, serious methodological problems hamper the clear understanding of IGF-I's significance in this context. Definitive determination of the role of insulin, IGFs and other growth factors in the development of diabetic vascular complications needs considerably more work. In any case, hyperinsulinemia is associated with a cluster of other accepted risk factors for cardiovascular disease which altogether resemble the entire insulin-resistance syndrome.

References

May 11, 1979·JAMA : the Journal of the American Medical Association·W B Kannel, D L McGee
Nov 22, 1979·The New England Journal of Medicine·D R ClemmonsL E Underwood
May 15, 1978·FEBS Letters·E Rinderknecht, R E Humbel
Aug 22, 1992·Lancet·R J Jarrett
Jul 1, 1990·Physiological Reviews·V R Sara, K Hall
Jul 1, 1990·Acta Endocrinologica·E M Rutanen, F Pekonen
May 1, 1991·Hypertension·P DelafontaineR W Alexander
Sep 1, 1991·American Journal of Hypertension·E Dall'AglioG M Reaven
Nov 1, 1991·Hypertension·G M ReavenH Chang
Jun 1, 1990·Diabetes Care·R W Stout
Dec 1, 1986·The Journal of Clinical Investigation·R C Baxter, J L Martin
Jun 1, 1989·Metabolism: Clinical and Experimental·S L HyerE M Kohner
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·P J GodowskiW I Wood
Nov 28, 1988·The American Journal of Medicine·R S BarA Sandra
Oct 1, 1988·The American Journal of Physiology·H L HachiyaG L King
Feb 1, 1988·Metabolism: Clinical and Experimental·M W Stolar
Jun 1, 1987·Acta Physiologica Scandinavica·E Jennische, H A Hansson
Nov 1, 1987·Hypertension·I S HwangG M Reaven
Jan 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P Rotwein
Jan 14, 1972·Nature·W H DaughadayJ J van Wyk
Mar 1, 1968·Diabetes·F I CairdG J Draper
Sep 1, 1983·The New England Journal of Medicine·T J MerimeeE R Froesch

❮ Previous
Next ❯

Citations

Jun 17, 2004·Journal of Neuropathology and Experimental Neurology·Robert E SchmidtAnders A F Sima

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.